@FiercePharma: ICYMI earlier: $GSK finally seals U.K. Bexsero deal for £20 per dose. FierceVaccines story | Follow @FiercePharma
@EricPFierce: ICYMI last week from FiercePharmaManufacturing: IPCA says FDA bans will have little sales impact. Didn't Wockhardt make that claim before its profits sank? More | Follow @EricPFierce
@CarlyHFierce: New fantasy: An Invokana/Vimizim final. Tell me that doesn't sound like a Halloween dream come true. Make it happen, people. #FierceMadness | Follow @CarlyHFierce
> The FDA has approved Novartis' ($NVS) Jadenu, a new formulation of Exjade, for iron chelation. Release
> Amneal Pharmaceuticals has announced a deal to acquire the generics business of Actavis Australia. More
> Actavis ($ACT) is set to save about €750,000 on energy bills, helping the company substantially cut its production costs. Report
> Novartis' Zykadia has cleared the first step in the U.K.'s early access scheme. More
> Teva ($TEVA) has launched a generic of Novartis' high-blood-pressure med Exforge in the U.S. Release
Medical Device News
@FierceMedDev: Medical device cybersecurity expert says better 'cybersecurity hygiene' needed. Article | Follow @FierceMedDev
@StacyALawrence: ICYMI: Philips brings in former Hologic CEO to head imaging biz in ongoing HealthTech revamp. Article | Follow @StacyALawrence
@VarunSaxena2: Japanese researchers study carbon nanotubes with drug delivery applications. FierceDrugDelivery story | Follow @VarunSaxena2
@EmilyWFierce: $PHG sold its lighting business for $2.8B. Bloomberg article | Follow @EmilyWFierce
> VA starts trial of mobile app to help manage PTSD symptoms. Story
> Philips sells LED, automotive lighting for almost $3B, readies to reinvest in HealthTech. Article
> Olympus settles accounting scandal as it struggles to address duodenoscope difficulties. Report
Biotech News
@FierceBiotech: Skincare startup bags $50M to get its acne drug into Phase III. Article | Follow @FierceBiotech
@JohnCFierce: Merck ties up with tiny Syndax on a 'breakthrough' cancer combo. News | Follow @JohnCFierce
@DamianFierce: This could be the lingering effects of watching Going Clear, but doesn't Jadenu sound like an evil space lord? Novartis' release | Follow @DamianFierce
> GlaxoSmithKline leads a $21M round for PhII kidney drug developer Thrasos. Story
> Aegerion reaches a cease-fire with its activist agitators. Article
> Fujifilm bags stem cell pioneer Cellular Dynamics in $307M buyout. Report
Drug Delivery News
> Genisphere boasts preclinical success of 3DNA platform for cataract complications. Report
> Columbia Labs picks up multidrug intravaginal ring created at MIT and MGH. More
> Researchers convert microbubbles to even smaller nanobubbles using ultrasound. Item
> Japanese researchers studying carbon nanotubes with drug delivery applications. Story
> Novan receives $50M in support of drug delivery tech to treat acne, HPV. Article
Pharma Manufacturing News
> Mylan recalling two injectable drugs made in India. Report
> Federal authorities raid Internet pharmacy operator CanadaDrugs.com. More
> Fujifilm expands in U.S. again with deal for stem cell producer. Story
> Roche's Genentech investing $125M in Oregon plant. News
> Sanofi vaccine plant in Canada again producing ImmuCyst bladder drug. Article
Pharma Asia News
> Japan pharma market on track for $80B mark by 2020, but obstacles seen. News
> Indian company says compulsory license use has cost country $10B in potential investments. Report
> China puts stem-cell clinical trial regulation in play with draft for comment. More
> 'Japanese NIH' launches April 1 with focus on devices and drugs. Story
> Chi-Med's fruquintinib meets metastatic colorectal cancer Phase II primary endpoint. Article
And Finally... The largest association of U.S. pharmacists has approved a measure calling on members to avoid participating in executions. Report